Catalyst Pharmaceuticals
CPRX
#3711
Rank
$3.85 B
Marketcap
$31.45
Share price
0.03%
Change (1 day)
50.12%
Change (1 year)

Catalyst Pharmaceuticals (CPRX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $0.13 Billion USD

According to Catalyst Pharmaceuticals's latest financial reports the company's total liabilities are $0.13 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalyst Pharmaceuticals - Total liabilities on balance sheet (from 2004 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$0.14 B20.95%
2024-12-31$0.12 B50.52%
2023-12-31$82.23 M9.34%
2022-12-31$75.2 M142.95%
2021-12-31$30.95 M36.04%
2020-12-31$22.75 M-8.04%
2019-12-31$24.74 M156.01%
2018-12-31$9.66 M118.51%
2017-12-31$4.42 M84.48%
2016-12-31$2.39 M-48.16%
2015-12-31$4.62 M-46.63%
2014-12-31$8.66 M117.83%
2013-12-31$3.97 M83.57%
2012-12-31$2.16 M-12.92%
2011-12-31$2.48 M693.27%
2010-12-31$0.31 M-9.99%
2009-12-31$0.34 M-76.34%
2008-12-31$1.47 M312.35%
2007-12-31$0.35 M-53.79%
2006-12-31$0.77 M125.33%
2005-12-31$0.34 M405.88%
2004-12-31$0.06 M
2002-12-31$0.06 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$119.70 B 88,629.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$117.21 B 86,781.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$57.72 B 42,689.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$1.67 B 1,140.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
$0.26 B 98.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$2.37 B 1,663.29%๐Ÿ‡บ๐Ÿ‡ธ USA